Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > AGM

<< Previous

Bullboard Posts

Next >>

Comment by Mannequinon May 09, 2023 11:44am

103 Views

Post# 35438612

RE:AGM

I agree that anything less that 70% means they should resign. In the 50%-60% range, they should be pushed out immediately. Without doing so, this shows the other members of the Board do not even care.

palinc2000 wrote: Voting results are quite a shellacking for BOD
Personnally I voted FOR only 3 Directors incl Paul and 2 others.
I voted against the Chairwoman and all those who agreed to Issue a Convert 5 years ago instead of issuing stock .
At minimum Board Members who received less that 70% FOR should resign as of NOW imo

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals